Atlas Trials

5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors

Clinical trial NCT00953394 · COMPLETED

Trial details

NCT number
NCT00953394
Sponsor
University of Turin, Italy
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2002-02-01
Primary completion
2006-02-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.